INTRODUCTION
Aberrant ion channel functions, or channelopathies, are a major cause of neurological disorders 1 .
Ionotropic glutamate receptors (iGluRs), including AMPA (AMPAR) and NMDA (NMDAR) receptor subtypes, are glutamate-gated ion channels found throughout the brain and participate in almost all brain functions. In terms of channelopathies, iGluR autoantibodies are associated with paraneoplastic encephalopathies and the neurological dysfunction in neuropsychiatric lupus 2, 3 .
Further, numerous de novo and inherited missense mutations have been identified in iGluR subunits that are associated with a wide spectrum of disorders, including epilepsy, intellectual disability, movement disorders, and schizophrenia [4] [5] [6] [7] .
iGluRs are highly modular proteins composed of four domains ( Figure 1a ) and function as tetrameric complexes 8 . Interestingly, missense mutations in the ligand-binding domain (LBD) and transmembrane domain (TMD) forming the ion channel are typically associated with more severe clinical phenotypes 7, 9 , reflecting their central role in agonist binding and ion channel opening. The ion channel core is formed by two transmembrane helices, M1 and M3, and an intracellular reentrant pore helix, M2 10, 11 . In eukaryotic iGluRs, there is an additional transmembrane helix, M4, that packs against the M1 and M3 helices of a neighboring subunit.
The M4 helix plays an important role in receptor biogenesis and ion channel function [12] [13] [14] .
In the NMDAR M4 segments, there are numerous missense mutations associated with clinical pathologies (Figures 1b & 1c ; Supplementary Table 1) . These mutations are primarily located in the extreme extracellular third of the M4 segments (Figure 1c ), which participates strongly in ion channel gating 15, 16 , implicating gating deficits as a potential cause for these disease phenotypes.
Here we address the contribution of these M4 missense mutations to receptor function.
Although many of these mutations impact receptor gating, the most notable and robust effects occur at a highly conserved glycine (Supplementary Figure 1) positioned near the extracellular end of the M4 segments. Missense mutations at this position in the GluN1 and GluN2B subunits have been identified in multiple patients, and the resulting changes in side chain properties can be either great (glycine-to-arginine) or subtle (glycine-to-alanine). For both NMDAR subunits, but most notably the obligatory GuN1 subunit, mutations at this conserved glycine drastically impair the stability of long-lived open states, greatly enhancing the rate of receptor deactivation as well as attenuating Ca 2+ permeability. Molecular dynamics simulations show that this glycine acts as a hinge, allowing for the C-terminal portion of the GluN1 M4 segment and the ion channel core to laterally expand. These results have strong implications for how neurological disorders are caused at the ion channel level and implicate the M4 as a major hub for modulation of ion channel function.
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RESULTS

Disease-associated missense mutations in the NMDAR M4 segments are prominent at glycines
At present, twenty-three patients with neurological disorders have been identified with de novo missense mutations in the M4 segments of NMDAR subunits ( Figure 1 ). The clinical phenotype for these patients is typically severe, encompassing epileptic encephalopathies and intellectual disabilities (Supplementary Table 1 ). For the majority of patients, the mutations occur at glycines (15 out of 23 patients). In transmembrane regions, the most common missense mutation associated with disease is glycine-to-arginine 17, 18 . Glycines often participate in critical structural roles in transmembrane segments, including acting as a notch for transmembrane segment interactions 19 and to provide flexibility to transmembrane segments 20 . Substitution of a charged side chain for a glycine can strongly disrupt these functions.
Of the 15 patients with missense mutations at glycines, 8 carry mutations to charged side chains: 6 are arginines (R) [GluN1(G815R), GluN1(G827R)] and 2 are glutamate (E)
[GluN2B(G820E), GluN2B(G826E)]. However, for a glycine at the external end of M4, a number of patients have mutations that have less dramatic changes in the nature of the side chain, from glycine to alanine (A) or valine (V). This glycine, G815 in GluN1, G819 in GluN2A, and G820 in GluN2B, is one of only three positions completely conserved across all mammalian iGluR M4 segments (Supplementary Figure 1a) and also shows considerable conservation across many different species (Supplementary Figure 1b) . That less dramatic missense mutations (e.g., alanine) can have a clinical phenotype and its conservation suggest that this glycine plays an important role in iGluR function.
Missense mutations in the NMDAR M4 segments dramatically alter receptor gating
The association of NMDAR missense mutations with neurological diseases could reflect alterations in the rules of NMDAR subunit assembly, trafficking 21 , interaction with other intracellular or extracellular proteins, and/or receptor functional properties such as gating, ion permeation or channel block 22, 23 . The majority of missense mutations in the M4 segment are positioned at the external ends, which participate strongly in gating and make no apparent contribution to a cell biological function (e.g., assembly) 15 . We therefore characterized the effect of many of these missense mutations on receptor gating (Figure 2 & Supplementary Figure 2) .
A critical determinant of synaptic NMDARs is their slow deactivation time course, which is GluN2-subunit specific [24] [25] [26] . Currents in human GluN1/GluN2A (hN1/hN2A) (Figure 2a, left) and GluN1/GluN2B (hN1/hN2B) ( Figure 2b , top), induced by a brief glutamate application as occurs at synapses, decay slowly with the time courses best fit by double exponentials (weighted ts, 81 ± 2 ms, n = 11 and 660 ± 30 ms, n = 8, respectively) (mean ± SEM, n = number of recordings) (Figures 2c & 2d; Supplementary Table 2) . As expected, the decay was much slower for GluN2B-containing receptors 25 .
Several of the missense mutations had no significant effect on deactivation times (Figures 2c & 2d, open bars), whereas two, hGluN2A(M817V) 16 and hGluN2(G826E), significantly slowed deactivation. However, the most prominent effects of the M4 missense mutations was a significant speeding of deactivation, which was notable for mutations at the conserved glycine in hGluN1, G815V (35 ± 4 ms, n = 5) and G815R (39 ± 2 ms, n = 6) ( Figure 2c , filled bars) and in hGluN2B, G820A (205.2 ± 12 ms, n = 7) (Figure 2d , filled bars). hGluN1(G815R) reduced the deactivation times by about half whether in the hGluN2A or hGluN2B background. We could not detect glutamate-activated whole-cell current for hGluN1(G827R)/hGluN2A or hGluN1/hGluN2B(G820E), either with brief or more sustained (Supplementary Figure 2) applications.
Although the missense mutations could have additional effects on receptor function (e.g., permeation) or cell biology, these strong effects on receptor deactivation (Figures 2c & 2d) as well as those on desensitization (Supplementary Figure 2) , presumably contribute to their associated clinical phenotype. Here we will focus on how these mutations impact receptor function.
Subsets of missense mutations strongly alter single channel activity
To begin to understand how the missense mutations impact receptor gating, we recorded single Table 3) , as found previously 27,28 . Certain missense mutations had no effect on activity (Figures 2f & 2h , open bars), whereas one, GluN2A(M817V), showed a significant potentiation 16 .
On the other hand, most tested missense mutations reduced single channel activity with the strongest effects occurring at glycines. At the conserved glycine, G815 in GluN1 and G820 in GluN2B, eq. Popen was less than 0.02 (G815V, 0.01 ± 0.005, n = 4; G815R, 0.02 ± 0.01, n = 5;
and G820A, 0.008 ± 0.0005, n = 4). For GluN1/GluN2B(G820E), which showed no whole-cell current amplitudes, no single channel activity could be detected ( Figure 2H ; Supplementary Table 3) . We detected single channel activity for a missense mutation at a glycine positioned more intracellularly, GluN1(G827R), for which we could not detect whole-cell current. Again, like other missense mutations at glycines, gating in GluN1(G827R) was strongly disrupted (0.02 ± 0.01, n = 4) ( Figure 2H ). The lack of detectable whole-cell currents for GluN1(G827R)
probably reflects that C-terminal positions in M4, especially this glycine, impact receptor surface expression 15 .
A missense mutation at the conserved glycine in GluN2B is pore dead.
The lack of glutamate-activated current for GluN2B(G820E), either in the whole-cell or on-cell configuration ( Figure 2 ), could reflect disrupted cell biology, either assembly and/or trafficking, or a complete lack of gating. To test these alternatives, we measured surface expression of GluN2B(G820E) using pHmystik, a pH-sensitive GFP, and TIRF microscopy 15 . In contrast to wild-type GluN1/GluN2A (Figure 3a ), wild-type GluN1/GluN2B showed poor surface expression (Figures 3b & 3d) with the strong background fluorescence presumably due to receptors trapped in the endoplasmic reticulum. In contrast, GluN1/GluN2B(G820E) showed robust surface expression (Figures 3c & 3d) . Thus, this missense mutation in GluN2B, G820E, at least in a diheteromeric form, is pore dead: it can get to the membrane surface but cannot gate, an effect found for other positions at the extracellular end of GluN2 M4 15 .
To further test the importance of the conserved glycine in GluN2B, we performed a rescue experiment in which we recorded single channel activity from triheteromeric receptors, where the receptor contains a single copy of G820E (Figures 3e-3h ). To generate triheteromeric receptors, we used NMDAR constructs having coiled-coiled domains 29 that permit only specific subunit combinations to reach the plasma membrane. The triheteromeric form, GluN1/GluN2B/GluN2B(G820E), is functional (Figure 3f ), but like other missense mutations at this conserved glycine, gating is severely restricted (eq. Popen, 0.007 ± 0.001, n = 3) (Figure 3h ).
In summary, many of the missense mutations in the M4 segment strongly restrict NMDAR gating (Figures 2 & 3; Supplementary Figure 3 ). These effects are notable at glycines, but are most severe at a conserved glycine, leading to in the diheteromeric form a receptor that transits to the membrane but is unable to gate (Figures 3a-3d ).
The conserved glycine is a key point in the M4 segments for receptor gating
The M4 segments must be displaced for efficient pore opening to occur 30 . One possible explanation for the effect of missense mutations at glycines in the various M4 segments is that these glycines provide local flexibility for the gating process to proceed. To test this possibility, we substituted each individual glycine in the M4 segments of GluN1, GluN2A, or GluN2B
( Figure 4a ), including those not associated with missense mutations, with alanine, which would constrain local flexibility 31 while not greatly altering local interactions as might occur with charged side chains. We measured single channel activity for these constructs (Figures 4b-4e ).
Many of the glycine-to-alanine substitutions in GluN1, GluN2A or GluN2B M4s either had
no effect (open bars) or weakly altered eq. Popen (G822 in GluN1). Notably, a charged missense mutation in a GluN1 glycine (G827R) had a dramatic effect on gating ( Figure 2F ), but the subtler alanine had no significant effect (Figure 4c ; Supplementary Table 4 ). In contrast, alanine substitutions at the conserved glycine in all three subunits, GluN1(G815A), GluN2A(G819A), and hGluN2B(G820A), dramatically altered gating, reducing eq. Popen to less than 0.01. Thus, the conserved glycine plays a unique role irreplaceable by any other side chain. Table 4 ). In addition, the alanine substitution in GluN1 reduced single channel activity to a simialr extent as the charged (G815R) missense mutation (Figure 2f ) or when tryptophan was substituted 15 .
The conserved glycine permits entry into long-lived open states allowing slow deactivation characteristic of synaptic NMDARs
To further address the impact of the conserved glycines to gating, we characterized closed and open time distributions of the glycine-to-alanine substitutions in GluN1 and GluN2A (Figures   5a-5c ). We focused functional experiments on GluN2A rather than GluN2B because of its more robust eq. Popen.
Our wild-type recordings were best described by 5 closed states (Figure 5a , left;
Supplementary Table 5 (Figure 5d ). Consistent with the reduced long open times, the deactivation times for GluN1(G815A) (11.3 ± 0.8 ms, n = 5) and GluN2A(G819A) (23.7 ± 0.7 ms, n = 5) were significantly faster than that for wild type (44.2 ± 1.5 ms, n = 5).
Paralleling the results for MOTs, deactivation for GluN1(G815A) was significantly faster than that for GluN2A(G819A) (Figure 5e alanine substitutions, the TMD Cα RMSDs increased and, paralleling the impact on MOT, the value was higher for GuN1(G815A) (3.1 ± 0.1 Å) compared to GluN2B(G820A) (2.7 ± 0.2 Å).
The Cα RMSDs for the TMD core (M1-M3) and the M4 segments showed similar trends ( Figure   6a ) though with greater changes over time for the M4 segments ( Figure 6b ). Thus, relative to wild type, introducing alanine at the conserved glycine in either GluN1 or GluN2B alters not only M4 but the entire TMD structure, with these effects stronger for GluN1(G815A). The M2 helix regulates Ca 2+ permeability in NMDARs 8 . We therefore measured relative Ca 2+ permeability using changes in reversal potential (Figures 7c-7d ) 36 . Wild-type GluN1/GluN2A, on going from 0 to 10 mM Ca
2+
, showed a change of reversal potential (DErev) of about 10 mV (9.5 ± 0.9 mV, n = 7), yielding a PCa/PNa of 4 (4.1 ± 0.6). For GluN1(G815A),
where the M2 pore size was reduced in the MD trajectory, the reversal potential change was significantly reduced (5.7 ± 0.5 mV, n = 8), corresponding to a decrease in PCa/PNa by about half (2.0 ± 0.2, n = 8). In contrast, GluN1/GluN2A(G819A), where pore size was not altered, PCa/PNa was not significantly changed (3.7 ± 0.6, n = 7).
We also measured Ca 2+ permeability for a missense mutation, G815R, at the conserved glycine in GluN1. For this construct, Ca 2+ permeability was altered to the same extent as the alanine (Figure 7d ) indicating that electrostatics do not contribute to the role of the GluN1 conserved glycine in modifying Ca 2+ permeability. 
The conserved glycine mainly in GluN1 permits C-terminal expansion of the ion channel
The NMDAR open state model was built using homology modeling of an AMPAR open One prediction arising from the MD simulations is that the glycine-to-alanine in GluN1 but not GluN2 restricts the pore diameter of the M2 pore loop (Figures 7a & 7b) . Supporting this observation is that Ca 2+ permeation in GluN1(G815A) but not GluN2A(G819A) was significantly reduced (Figures 7c & 7d) . This result supports the relative differences in the MD simulations and also indicates that pore expansion impact the high Ca 2+ influx mediated by
NMDARs.
That glycine-to-alanine substitutions at neighboring positions in the M4 segments had no significant effects on receptor gating ( Figure 4 ) suggest that, rather than merely providing local flexibility to the M4 segments, the conserved glycines play unique roles irreplaceable by any other side chain. In part it may reflect that the relative positioning of the glycine in the M4 helix is critical, with structural elements positioned external to the glycine being involved in critical interactions 22 and those internal to the glycine requiring flexibility 15 . In addition, the open state model suggests a Cα hydrogen bond that connects the S1-M1 directly to the conserved glycine in the M4 34 , which could also alter receptor gating.
We also envision that the M4 is passively, not actively, splaying in response to pore opening. Consistent with this idea, specific side chain interactions of the C-terminal two-thirds of the M4 helix appear unimportant to gating 15 as would be expected if it acted permissively.
Stability of NMDAR open state in the pathogenesis of neurological disorders
Given the high number of patients identified with mutations in the conserved glycine relative to other M4 transmembrane segment mutations, it is unlikely that mutations at this site are merely epiphenomena. Indeed, such drastic alterations in NMDAR structure and subsequent dysfunction imply a causal relationship. One therefore asks what aspect of this dysfunction plays the dominant role in the pathogenesis of these disorders. Notably, most M4 missense mutations that we measured had reduced channel activity characterized by a destabilized open state (Figure 2 ).
Though a reduction in excitatory glutamatergic activity leading to epilepsy may seem counterintuitive, it most likely changes the balance of excitation and inhibition in the nervous system.
The most identifiable pathology amongst these mutations is epilepsy. However, a dysfunction common to nearly all M4 missense mutations is intellectual disability (Supplementary Table 1 ), suggesting that the problem may lie in development. The GluN2B subunit, which carries numerous mutations at the conserved glycine, is most highly expressed before birth
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. GluN1, being an obligate subunit, is expressed at all stages of development.
Interestingly, the absence of any conserved G mutants in GluN2A, a subunit that is primarily expressed in the adult brain, suggest that pathogenesis of these disorders strongly involves the NMDARs role in the developing brain.
The M4 segments as a hub of NMDAR modulation
The M4 transmembrane helix in iGluRs is the most peripheral transmembrane segment in the iGluR ion channel, interacts with lipids, and is attached to the regulatory C-terminal domain. (c) The GluN1, GluN2A, and GluN2B M4 segments indicting the specific location of missense mutations. Each dot represents a patient in which the mutation has been identified (Supplementary Table 1 Table 2) . No whole-cell current could be detected for hGluN1(G827R)/hGluN2A or hGluN1/hGluN2B(G820E), which were tested on at least three different transfection cycles (Supplementary Figure 2) . Solid bars indicate values significantly different from wild type (p < 0.05, t-test).
(e & g)
Example single channel recordings of hGluN1/hGluN2A (e) or hGluN1/hGluN2B (g) or the same receptor containing missense mutations at the conserved glycine. Recordings were performed in the on-cell configuration (holding potential, +100 mV). Downward deflections are inward currents. For each construct, the top half shows a low-resolution (filtered at 1 kHz) and the bottom half a higher resolution portion of same record (3 kHz).
(f & h)
Equilibrium open probability (eq. Popen) (mean ± SEM, n > 4 patches) for hGluN1/hGluN2A (f) or hGluN1/hGluN2B (h) (Supplementary Table 3 Recordings displayed as in Figure 2E . 
ONLINE METHODS
Molecular biology and cell culture
All manipulations were made in rat GluN1 (GluN1a) (NCBI Protein database accession no.
P35439), GluN2A (Q00959), or GluA2 (P19491) subunits or human GluN1 (hGluN1; Q05586), GluN2A (hGluN2A; Q12879), or GluN2B (hGluN2B; Q13224) subunits. Unless otherwise noted constructs tested were rat. In all instances, numbering included the signal peptide (GluN1, 18 residues; GluN2A, 19 residues; GluN2B, 26 residues; GluA2, 21 residues). Mutations were generated via QuickChange site-directed mutagenesis (Agilent) with XL1-Blue super-competent cells.
Cell Triheteromeric expression system. NMDARs are obligate heterotetramers typically composed of 2 GluN1 and 2 GluN2 subunits. Co-expression of wild-type GluN1 and GluN2A and a subunit with a mutation[e.g., GluN2A(mutation)] would result in three populations of cell-surface expressed receptors: GluN1/GluN2A (di-heteromeric); GluN1/GluN2A/GluN2A(mutation) (triheteromeric); and GluN1/GluN2A(mutation) (di-heteromeric). To restrict surface expression to defined tri-heteromeric receptors, we used the 'triheteromeric' system developed by the
Traynelis lab
29
, which is based on leucine zipper motifs from GABAB receptors and ER retention/retrieval motifs introduced into the C-terminal domain of NMDAR subunits. All constructs were kindly provided by Dr. Kasper Hansen (University of Montana). Homology modeling. We used homology modeling to build an initial model for the GluN1/GluN2B receptor in the open state (without the disordered C-terminal domain) 39 . We then introduced glycine-to-alanine mutations at the conserved position, producing the N1(G815A)/N2B and N1/N2B(G820A) mutants. For the wild-type open model, we chose PDB entry 5FXG 40 as the template for the extracellular amino-terminal domain (ATD) and LBD 34 , and 5WEO 35 as the template for the TMD. The templates were both aligned to the closed NMDAR structure 4TLM 41 . We then used Modeller 9.18 42 for homology modeling, including generation of missing residues.
Molecular modeling and simulations
Our previous study 34 suggested that interactions between the pre-M1 helix and the extracellular end of the M4 helix are important for stabilizing the open state. Among these interactions are special hydrogen bonds formed with the Cα atoms of the conserved glycines as donors. Here we introduced such hydrogen bonds into our initial open model, in a 14-ps fine-tuning simulation in vacuum using NAMD 2.11. In this simulation, all Cα atoms were restrained with a force constant of 5 kcal mol -1 Å -2 except for residues K544-Q559 in GluN1 and R540-S555 in GluN2B containing the pre-M1 helices. In addition, Cα atoms of G815 in GluN1 and G820 in GluN2B were restrained to a hydrogen-bonding distance of 3.2 Å from backbone carbonyl oxygen atoms of L551 in GluN1 and P547 on GluN2B, respectively, with a force constant of 0.1 kcal mol -1 Å -2 . The G815A mutation in GluN1 and G820A mutation in GluN2B
were made using VMD 43 to produce open models for the two mutants.
Molecular dynamics (MD) simulations.
Following our previous study 34 , MD simulations were carried out for the TMD construct, consisting of residues L541-P670 and R794-A841 in GluN1
and M539-K669 and G799-F845 in GluN2B, truncated from our full-length models. The four LBD-proximal residues of the LBD-TMD linkers (L541-K544, I667-P670, R794-E797 in GluN1
and M537-R540, L666-K669, G799-H802 in GluN2B) were restraint to mimic the agonistbound form of the LBD that maintains channel opening. The TMD construct was embedded in a membrane bilayer composed of 222 POPC lipids, and solvated by 25,000 water molecules and 0.15 M NaCl, using CHARMM-GUI 44 . CHARMM-GUI's standard 6-step equilibration protocol was followed to equilibrate the system. An additional equilibration step of 12 ns was used to ramp down the restraints on the Cα atoms except for the LBD-proximal linker residues. The final production run was 500 ns with restraints on the LBD-proximal linker Cα remain at 5 kcal mol
Starting from the CHARMM-GUI's equilibration step, simulations were performed using AMBER 14 on GPUs 45 with CHARMM36 force field 46 . The time step was 2 fs. Nonbonded interactions were cut off at 8.0 Å, and the particle mesh Ewald method was used for long-range electrostatic interactions 45 . The NPT ensemble was used in simulation, with temperature controlled at 300 K by Langevin dynamics and pressure controlled at 1 bar by the Berendsen method 47 .
Analysis. MD trajectories were saved once every 100 ps (5,000 frames for each construct). Rootmean-square-deviations (RMSDs) were calculated using Cα atoms of either all the helical segments (M1-M4) or only M1-M3 in the ion channel core. In the latter case, the RMSD for M4
was also calculated using the structural alignment on M1-M3. The reference for all the RMSD calculations was the homology model. The aligned structures were used to calculate an average structure, which was then used to select a representative snapshot from each MD trajectory. The pore radii along the pore axis were calculated using the HOLE program 48 on every 10th of the saved frames.
Macroscopic current recordings
Macroscopic currents in the whole-cell mode or outside-out patches, isolated from HEK 293 cells, were recorded at room temperature (20-23°C) using an EPC-9 or EPC-10 amplifier with
Patchmaster software (HEKA Elektronik, Lambrecht, Germany), digitized at 10 kHz and lowpass filtered at 2.8 kHz (-3 dB) using an 8 pole low pass Bessel filter. Patch microelectrodes were filled with our standard intracellular solution (in mM): 140 KCl, 10 HEPES, 1 BAPTA, pH 7.2 (KOH). Our standard extracellular solution consisted of (in mM): 140 NaCl, 1 CaCl2, 10 HEPES, pH 7.2 (NaOH). Pipettes had resistances of 2-6 MW when filled with the pipette solution and measured in the standard Na + external solution. We did not use series resistance compensation nor did we correct for junction potentials. Currents were measured within 15 minutes of going whole-cell.
External solutions were applied using a piezo-driven double barrel application system. The open tip response (10-90% rise time) of the application system was between 400-600 µs. For display, NMDAR currents were digitally refiltered at 500 Hz and resampled at 1 kHz.
Rates of deactivation and desensitization. To determine the rates of activation and deactivation, we applied glutamate for 2 ms at -70 mV in the whole-cell mode. For activation times, we used the 10-90% rise time. Deactivation times (weighted ts) were derived by fitting the decay phase of currents with a double-exponential function. To determine the extent and rate of desensitization, we applied glutamate at -70 mV for 2.5 secs in the whole-cell mode. Percent desensitization (% des) was calculated from the ratio of peak (Ipeak) and steady-state (Iss) current amplitudes: %des = 100 x (1 -Iss/Ipeak). Time constants of desensitization were determined by fitting the decaying phase of currents a double-exponential function. In some instances when current amplitudes were small, we averaged 3-12 records.
Ca 2+ permeability. To quantify Ca 2+ permeability, we measured changes in reversal potentials, DErev, for glutamate-activated currents on replacing a reference solution (140 mM NaCl, 10 mM HEPES, 0 added Ca 2+ , pH 7.2, NaOH) with a test solution (the same solution but with added 10 mM CaCl2). Ca 2+ permeability ratios (PCa/PNa) were calculated using the Lewis equation 36 . We did not correct for activity coefficients.
Single-channel recordings and analysis
All single-channel recordings were performed in the on-cell configuration at steady state. The pipette solution, which mimicked extracellular agonist conditions, contained (in mM): 150 NaCl, 10 HEPES, 0.05 EDTA, 1 glutamate, and 0.1 glycine, pH 8.0 (NaOH). The high pH and EDTA were used to minimize proton and divalent mediated inhibitory effects, respectively 27 . Recording pipettes were pulled from thick-wall borosilicate capillary glass (Sutter Instruments) and fire- for those constructs with a low equilibrium Po, we used an approach as described previously 30 .
Assaying surface expression using pH sensitive GFP
Surface expression was assayed as described previously 15 . Briefly, HEK 293T cells were imaged 24-48 hours post-transfection using a Nikon Ti Eclipse microscope equipped with the Nikon Figure 1 . Topology of NMDA receptors and distribution of missense mutations in and around the M4 transmembrane segments (a) Model NMDAR structure (structure based on 4TLM of GluN1/GluN2B) [Amin, 2017 lacking the intracellular C-terminal domain (CTD). Subunits are colored light orange (GluN1) and gray 60% (GluN2). For iGluRs, the tetrameric complex is composed of four highly modular domains: the extracellularly located amino-terminal (ATD) and ligand-binding (LBD) domains; the membranespanning transmembrane domain (TMD) forming the ion channel; and the CTD. Positions highlighted in magenta are disease-associated missense mutations in the GluN1, GluN2A, or GluN2B M4 transmembrane segment or the S2-M4 linker (L812M and I814T in GluN2A). (b) An enlarged view of the extracellular end of the TMD highlighting the distribution of missense mutations in and around the M4 segments. (c) The GluN1, GluN2A, and GluN2B M4 segments indicting the specific location of missense mutations. Each dot represents a patient in which the mutation has been identified (Table S1 ). The dashed line separates M3 (leftside) versus lipid (rightside) facing portions of the M4 transmembrane segment. (Table S2) . No whole-cell current could be detected for (Table S5) , whereas open time histograms were best fit typically with 4 (wild type), 2 (GluN1(G815A)), or 3 (GluN2A(G18A)) exponentials (Table S6) 
